PUMA BIOTECHNOLOGY, INC.

PBYI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Jan 3, 2025 FORM 4
4 Jan 3, 2025 FORM 4
4 Jan 3, 2025 FORM 4
144 Jan 2, 2025
144 Jan 2, 2025
144 Jan 2, 2025
144 Jan 2, 2025
SCHEDULE 13G/A Nov 14, 2024
SC 13G Nov 8, 2024
10-Q Nov 7, 2024 FORM 10-Q
8-K Nov 7, 2024 FORM 8-K
SC 13G Oct 22, 2024
8-K Sep 16, 2024 FORM 8-K
S-8 Aug 27, 2024 FORM S-8
8-K Aug 15, 2024 FORM 8-K
4 Aug 13, 2024 FORM 4
144 Aug 12, 2024
8-K Aug 7, 2024 FORM 8-K
10-Q Aug 1, 2024 FORM 10-Q
8-K Aug 1, 2024 FORM 8-K
4 Jul 18, 2024 FORM 4
4 Jul 18, 2024 FORM 4
4 Jul 18, 2024 FORM 4
4 Jul 18, 2024 FORM 4
144 Jul 17, 2024
← Newer Page 5 of 45 · 1117 filings Older →